Share Name Share Symbol Market Type Share ISIN Share Description
Microsaic Systems Plc LSE:MSYS London Ordinary Share GB00B547ZY09 ORD 0.25P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.025 -4.55% 0.525 1,439,107 15:55:37
Bid Price Offer Price High Price Low Price Open Price
0.45 0.60 0.55 0.525 0.55
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 0.87 -3.10 -0.61 2
Last Trade Time Trade Type Trade Size Trade Price Currency
15:52:59 O 536,421 0.4502 GBX

Microsaic Systems (MSYS) Latest News (1)

More Microsaic Systems News
Microsaic Systems Takeover Rumours

Microsaic Systems (MSYS) Discussions and Chat

Microsaic Systems Forums and Chat

Date Time Title Posts
12/8/202009:55Microsaic Systems670
09/3/202007:43Microsaic - Another pump and dump disaster80
09/3/202007:43Microsaic Systems - 2018990
24/7/201812:24Microsaic - miniaturised chip-size scientific instruments11
24/7/201812:23Microsaic Systems - 20111,548

Add a New Thread

Microsaic Systems (MSYS) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Microsaic Systems trades in real-time

Microsaic Systems (MSYS) Top Chat Posts

Microsaic Systems Daily Update: Microsaic Systems Plc is listed in the Software & Computer Services sector of the London Stock Exchange with ticker MSYS. The last closing price for Microsaic Systems was 0.55p.
Microsaic Systems Plc has a 4 week average price of 0.35p and a 12 week average price of 0.35p.
The 1 year high share price is 1.90p while the 1 year low share price is currently 0.33p.
There are currently 456,365,146 shares in issue and the average daily traded volume is 1,594,240 shares. The market capitalisation of Microsaic Systems Plc is £2,395,917.02.
kingston78: It takes a long time to build up a business and a distribution network. Someone somewhere would probably like to take this company over for a "small" price for long term gain. The share price will be at least 1 p .
thesageofsaint: I had been thinking for a while now if MSYS equipments could be used to analyse and detect CV19. The total meltdown it has caused will lead to some very irrational actions. Within this context it is not beyond reason that many processes for the Pharma and particularly food industries may have mandated CV19 inline process testing for CV19 to secure safe manufacturing and packaging regimes. With distribution arrangements in place, this could literally explode in price if there is any movement along this path. An RNS that states they have diversified objectives to this focus would drive the share price in to double digits in a day. Very interesting.
no1larafan: Raised £5.5 million 2 years ago at 2p which was a discount of approx 11% to the previous days share price, spo I wouldn't expect a heavily discounted share placing, also the company is in a much better position than 2 years ago so this will hopefully be the last ever placing as they should go into profits over the next 2 years, all imo.
knowing: Well people maybe have forgotten the tie up with their Chinese Partner.
bones: Should fire ahead on the upbeat talk. One area not mentioned though is the likelihood of a new placing during 2020 as cash is down to £2.6M and the company gets through about that amount every year. Turnover will have to accelerate substantially to put that off. The company will want to talk the share price up as much as possible to get a good placing price away eventually? A good deal on bioprocessing may change all that! EDIT: crossed with the last two posts, same message on cash.
garth: Dave, why are you in this one? I have had a look at it a couple of times. At circa £300K revenue and losses circa 5 times that they just look in trouble down the line. Being valued at cash doesnt help - if the cash is heading down the drain then the share price can reasonably be expected to do the same... What am I missing? G.
bones: Two weeks ago, a massive amount (relative to market size) was wagered on MSYS. It is not entirely clear why as all the buyers were sold into by person or persons unknown but likely an institution. It has been common in recent times for small cap funds to be distressed sellers (Miton an obvious example) as punters pulled funds from open-ended vehicles post-Brexit and especially after the late 2018 market wobble. Hence many a time have we seen an institution bailing out wholesale giving a massive buy signal as an overhang clears just before news hits. In fact, see my chart of RENE a few posts back and much of that big volume day can be attributed to Invesco bailing out a 12% holding in full, with share price multiplying soon after. Exactly the same happened in 2017 with VRS (15% owner Odier Asset sold and price multiplied in the months after). Just in April, I know that an institution bailed from WEY at 5p. I was on that and it doubled within a month. Now, it appears likely a 5%+ holder has bailed from MSYS (although we haven’t been notified) in early June. What next? Look at that “bowl” forming in the MSYS 2 year chart in the header. It looks good for further progress.
bones: Pennyfalls. 7 Jun '19 - 16:58 - 95 of 97 Just out of interest, fellas, does anyone hold here long enough to understand the back-story and why the shares crashes a few years ago from circa 50p? Was this the usual Phrama case of major dilution, early unproven tech etc? Just wondering what the (brief) story was that got it down to circa 1p from those heights? Valid question Pennyfalls, so I took a quick look through Companies House accounts and some RNS’s and it seems to me that since flotation in 2011, the company has perpetually made losses around £2M annually due to an inability to find sufficient sales for its traditional small molecule mass spectrometer technology whilst constantly spending on R&D to improve the products and look for new technological advances. Because of the losses, the company has also regularly made placings starting off in the early days around 30p to 40p per share but as losses built and strategies failed, placings became ever more dilutive due to a collapsing share price, culminating in the last placing at 2p last year which created more shares than already existed. No wonder then that the share price has gone from 50p to 1p! My general view is that, up to very recently, the management haven’t really been very good! There seemed to be the old founders who were hanging on but these were really academics who tried to commercialise out of the Imperial College, London. Boffins don’t make money, they research and discover things. However, it does seem that the old guard has eventually left the building, whether walked or pushed. There has been a regular turnover of other executives too in recent years, partly I expect in the vain hope of finding the right people to take this forward. That is never a happy scenario. I am new to this company but it seems there is some confidence that Glenn Tracey may just be the CEO to do it right. The company seems to be accelerating signing up distribution deals for its old MS products around the world whilst good technological progress is being made with the protein identification and bioprocessing areas using MSYS technology. As I see it, the share price has a lot of baggage to shed and that is proving hard to shake off but, whisper it quietly, maybe the stars are aligning with commercial successes coming thanks to a much less flabby, complacent management team?
robste: I don't see how anyone is taking profits or making money selling at these prices. It can only be a lack of patience in the share price causing this decline. In the past MSYS seems to have attracted more than its fair share of short term investors who buy in, wait for a spike, sell and then wait for the all selling to reduce the share price so that they can buy in cheaply again. They aren't interested in long term progression, just that there are numerous and regular spikes that they can profit from. Whilst we all do this to some extent, there is a saturation point at which the sheer volume of people rushing to sell the moment the share price turns blue, actually causes a decline of the share price that it can't recover from, and the spikes stop coming. Thats what I see happening here recently. The last couple of postive RNS announcements haven't caused the expected spike and the short term investors are now moving their money elsewhere. I don't see this as a negative thing. I feel that MSYS is a medium to long term investment, and maybe when the share price inevitably starts to rise again it will do so in a much better slow and steady increase rather the up and down to stand still activity we have experienced in recent times.
robste: Hi folks. First time poster here. I only have a modest investment in this share compared to some of you (25,000 shares @ 2.16p) but I've long since given up on trying to find some logic behind the share price. It seems to me that the share price no longer reflects the activities or potential of the company, but rather it reflects the way in which the shares are being traded. MSYS has become an ideal stock for short term investors, and the sheer volume of people hitting the sell button almost the very moment the share price turns blue, inevitably sees it tumble back down to a base price within 24 hrs of the company publishing positive news. The rush to sell is creating a virtual ceiling from which this share price cannot currently escape and its difficult to see how this might change in the short term. I notice that some companies are looking at share consolidation as a means of trying to break this cycle and reduce volatility. Oxford Biomedica I suppose being the most recent example. A different company in different circumtances I know, but they are doing a 50 to 1 consolidation, turning a 15p share price into a 750p share price. Does anyone think that consolidation might be an option here in the future?
Microsaic Systems share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Microsaic ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200815 17:16:29